Bipartisan 21st Century Cures Initiative Continues in Colorado This Week

Press Release

The bipartisan 21st Century Cures initiative heads to Colorado on Wednesday, September 3, as Rep. Diana DeGette (D-CO) hosts a panel of national and local health care leaders, thinkers, and innovators for a roundtable to discuss opportunities to accelerate the discovery, development, and delivery of new cures and treatments. Wednesday's roundtable will begin at 9:30 a.m. MT at National Jewish Health in Denver, Colorado. DeGette partnered with full committee Chairman Fred Upton (R-MI) to launch this initiative earlier this year.

"I am excited to have Colorado's health and research leaders join top federal officials to discuss ways to speed the delivery of medical cures," said DeGette. "The 21st Century Cures initiative will support America's preeminence in medical research for decades to come, and Colorado's experts offer valuable insights toward this effort."

Participants in Wednesday's event include:

-Dr. Eric Green, Director, National Human Genome Research Institute, National Institutes of Health

-Dr. Janet Woodcock, Director, Center for Drug Evaluation and Research, Food and Drug Administration

-Dr. Frank Accurso, Director, Cystic Fibrosis Clinical Research, Children's Hospital Colorado and University of Colorado Denver

-David Brunel, CEO, Biodesix

-Dr. David Schwartz, Director, Personalized Medicine Initiative, Chair of the Department of Medicine, University of Colorado

-Dan Theodorescu, Director, Cancer Center, University of Colorado

-Dr. Gregory P. Downey, Executive Vice President of Academic Affairs and Professor of Medicine and Pediatrics at National Jewish Health

Members have also hosted 21st Century Cures events in New Jersey, Florida, Ohio, Indiana, and Pennsylvania over the past several weeks.

Learn more about 21st Century Cures online here, like the initiative on Facebook, follow @ECCures on Twitter, join the conversation using #Path2Cures, and share your ideas with cures@mail.house.gov.

Source